ECJ Appeal – Medicinal products for human use – Suspension of the marketing and the withdrawal of certain consignments of medicinal products containing the active ingredient Clopidogrel -Variation of marketing authorisations – Prohibition on marketing – Regulation (EC) No 726/2004 and Directive 2001/83/EC – Precautionary principle – Proportionality – Obligation to state reasons
A. Borg Barthet, P
C-269/13, [2014] EUECJ C-269/13
Bailii
Regulation (EC) No 726/2004, Directive 2001/83/EC
European
Updated: 02 December 2021; Ref: scu.523682